Objective: Brain hypothermia controls epileptic discharge and reduces extracellular concentrations of glutamate (Glu), an excitatory neurotransmitter. We aimed to determine the effects of focal brain cooling (FBC) on levels of c-aminobutyric acid (GABA), which is a major inhibitory neurotransmitter. The relationship between Glu or GABA concentrations and the severity of epileptic symptoms was also analyzed. Methods: Patients with intractable epilepsy underwent FBC at lesionectomized (n = 11) or hippocampectomized (n = 8) regions at 15°C for 30 min using custommade cooling devices. Concentrations of Glu (n = 18) and GABA (n = 12) were measured in extracellular fluid obtained through microdialysis using high-performance liquid chromatography (HPLC). The reduction rate of neurotransmitter levels and its relationship with electrocorticography (ECoG) signal changes in response to FBC were measured. Results: We found no relationship between the concentrations of Glu or GABA and seizure severity. There was a significant decrease in the concentration of Glu to 66.3% of control levels during the cooling period (p = 0.001). This rate of reduction correlated with ECoG power (r 2 = 0.68). Cortical and hippocampal GABA levels significantly (p = 0.02) and nonsignificantly decreased to 47.7% and 32.4% of control levels, respectively. However, the rate of this reduction did not correlate with ECoG (r 2 = 0.11). Significance: Although the decrease in hippocampal GABA levels was not significant due to wide variations in its concentration, the levels of cortical GABA and Glu were decreased following FBC. FBC suppresses epileptic discharge and the release of both excitatory and inhibitory neurotransmitters. The reduction in Glu levels further contributes to the reduction in epileptic discharge. However, the reduction in the levels of GABA has no impact on ECoG.
neurotransmitter, is known to be dysfunctional in patients with epilepsy. 2 Decreases in GABA A receptors within epileptic foci are evident through autoradiographic imaging of the benzodiazepine (BDZ) receptor, which exists in complexes with GABA A receptors. 3, 4 Despite the decreased numbers of GABA A receptors in patients with epilepsy, some investigators have found that basal GABA release increases epilepsy by the continuous excitability of presynaptic neurons. 5 However, others have reported that GABA release is unchanged in epilepsy. 6, 7 Measurements of GABA in patients during general anesthesia indicate that extracellular concentrations of GABA increase 84-fold above basal release levels during epileptic discharge. 8 Increases in GABA levels were also observed after potassium-induced discharges in en bloc resection slices from the human hippocampus, 9 and during pilocarpine-induced seizures in free-moving rats. 10 Although the basal and activated levels of GABA have been established, decreases in GABA levels during neuronal suppression have only been investigated using magnetic resonance spectroscopy (MRS) in neonates treated with therapeutic hypothermia. 11 We have developed a novel treatment for intractable epilepsy with unresectable foci using focal brain cooling (FBC). Brain temperatures of 15°C or lower cause epileptic behaviors and discharges to cease and lead to a decrease in the concentrations of glutamate (Glu) in the human brain. 12 Inhibition of Glu release is not observed in the postischemic rat brain when the brain is cooled to 33.5°C. 13 This suggests that whole body hypothermia cannot be used as an alternative to FBC to reduce Glu levels. We measured extracellular Glu and GABA levels in patients with epilepsy using microdialysis to investigate whether a brain temperature of 15°C decreases GABA levels and shifts the balance between Glu and GABA. We classified patients into hyper-and hypoglutamatergic groups and hyper-and hypo-GABAergic groups according to their basal concentrations of these neurotransmitters in order to analyze correlations between neurotransmitter levels and the frequencies of complex partial seizures (CPS) and generalized tonic convulsions (GTC). This is the first report of GABA concentrations in the human brain at 15°C.
Methods

Patients
Nineteen patients with intractable partial epilepsy (temporal lobe epilepsy, 14; extratemporal lobe epilepsy, 5; age: 6-58 years, 13 male and 6 female) were enrolled in this study (Table 1) . Epileptic foci were detected using subdural or depth electrode recordings during long-term video-electroencephalography (EEG) in 18 patients. In one exceptional patient with an astrocytoma, the resection and cooling site was determined using magnetic resonance imaging (MRI) and intraoperative electrocorticography (ECoG). All patients met the surgical indication for lesionectomy or temporal lobe resection with or without hippocampectomy. Seizure type, frequency, MRI findings, histopathology, 123 Ilabeled iomazenil (IMZ) single-photon emission computed tomography (SPECT), and anticonvulsant use are listed in Table 1 .
The study protocol was reviewed and approved by the institutional review board at Yamaguchi University (H22-46-4) and conformed to the Helsinki Declaration. The 15°C cooling procedure, which lasted 30 min, was limited to the epileptogenic zone or the seizure-onset zone, which were resected. The safety of exposing the human brain to a temperature of 15°C had already been demonstrated in previous studies. [14] [15] [16] [17] The patients and their families provided written consent to participate in our study after being adequately informed of the aims of our study, its methods, and the anticipated benefits, as well as the potential risks and discomforts associated with their involvement. All patients had the right to withdraw from the study at any time.
Cooling devices
The cooling devices used have been described previously. 12 In brief, a thermoelectrically driven cooling device, originally developed in our laboratory 14, 15, [17] [18] [19] • Glu levels were significantly decreased to 66.3% of control levels after cooling to 15°C; this reduction correlated with the reduction in ECoG power
• Cortical GABA levels were significantly reduced to 47.7% of control levels during brain cooling; this reduction did not correlate with the reduction in ECoG
• Brain cooling decreased discharge and neurotransmitter release; reduction in the levels of Glu, but not GABA, further contributed to the decrease in discharge two water channels inside, was connected to the portable heat-processing component via medical catheters (Tygon, R-3603, U.S.A.). The module (width 9 diameter 9 height = 110 9 47 9 140 mm 3 ; total weight = 685 g) comprised a reservoir filled with Ringer's solution (85 ml) maintained at 15°C by a thermoelectric chip (29.8 9 29.8 mm 2 ; I max : 4.0 A, V max : 9.8 V, Q max : 21 W), an air-cooling fan, and a direct current (DC)-driven pump (flow rate of 50 ml/min) (Fig. 1A) . The cooling device used for the hippocampus was a handheld-type device. It consisted of a thermoelectric chip (10 9 10 mm 2 ; I max : 0.8 A, V max : 8.8 V, Q max : 4.2 W; Ferrotec) with an attached silver plate on the cooling side, and a silver heat sink (10 9 10 9 4 mm 3 ) and a catheter embedded in the cylindrical acrylic case (diameter, 16 mm; length, 150 mm) (Fig. 1B) . This cooling device was connected to the same heat-processing component as above via medical catheters.
Procedures
The cooling and measurement procedures have been described previously. 12 In brief, the patients were anesthetized using 2.5% sevoflurane in order to irritate the foci. The cooling device was placed on the epileptic cortex in patients 1-11 in Table 1 (Fig. 1A) . In cases of temporal lobe (patients 12-19 in the Table 1), the equipment was placed on the hippocampal head after removal of the anterior temporal lobe (Fig. 1B) . The device was controlled such that the temperature of the brain surface immediately reached15°C, and was maintained at this temperature for 30 min. The device discontinued cooling the brain and controlling the temperature during the rewarming period, allowing the temperature of the brain to return to normal within 30 min. ECoG (n = 12) was performed for the cooled region under differential amplification and brain activity conditions at a sampling rate of 1 kHz. Temporal frequency analyses of ECoG were performed off-line (SciWorks; DataWave Technologies, U.S.A.). Glu (n = 18) and GABA (n = 12) levels were sampled and measured using an automated analyzer (CMA-600 Microdialysis Analyzer, Sweden). Microdialysis probes were inserted into the cortex or the hippocampus. The probe was inserted into the peritumoral area in the patient with dysembryoplastic neuroepithelial tumor (DNET) and cavernoma, whereas, it was inserted into the tumor in the patient with astrocytoma because the tumor was exposed to the subarachnoid space following a previous surgery. After a 15-min stabilization period required for preventing the traumatic leakage of neurotransmitters from cells and synapses, samples from the pre-cooling, cooling, and postcooling stages were collected for 30 min each. Ringer's solution was perfused throughout the procedure at a flow rate of 0.3 ll/min. We then performed the temporal lobectomy, lesionectomy, and/or hippocampectomy. We also performed histopathologic diagnoses and analyzed the effects of the cooling on the resected cortices and hippocampi. Outcomes of the surgeries are listed in Table 1 .
Statistical analysis
Values are displayed as means AE standard errors of the mean (SEMs). Statistical differences between the pre-cooling and cooling periods and those between the pre-cooling and post-cooling periods were assessed using paired t-tests. We performed univariate analyses between the groups based on Glu or GABA concentrations using chi-square tests. A p-value of <0.05 was considered statistically significant. The contribution rates of the different factors were calculated using Pearson's simple linear regression method. These analyses were performed using StatMate IV (ATMS, Japan).
Results
The average temperature of the cortical and hippocampal surfaces without cooling was 34°C. Both decreased to 15°C
A B Epilepsia ILAE within 5 min after induction of the cooling and recovered to the same level within 5 min after the cooling was terminated. Spike discharges were observed before the cooling and were suppressed during the cooling. Power analysis of the ECoG revealed that the power was 2.53 AE 6.18 9 10 À9 V 2 before cooling and was reduced to 0.48 AE 0.82 9 10 À9 V 2 (p = 0.14) by the cooling. This reduction persisted after the cooling was stopped (0.45 AE 0.81 9 10 À9 V 2 , p = 0.14, Fig. 2 ). Because the standard deviations were too large, these reductions were not statistically significant.
The concentration of Glu in the precooling period was 65.5 AE 18.7 lmol/L (n = 18). Patients were divided into two groups according to the concentration of Glu. Specifically, we divided the patients into hyper-and hypoglutamatergic groups using a Glu concentration cut-off of 50 lmol/L. No significant differences were observed between the two groups in seizure frequency, seizure type, use of sodium channel blockers or BDZ receptor agonists, or BDZ receptor defects found using IMZ-SPECT. There were no differences in the number of patients younger than 20-years-old or in the number of measurements in the patients' cortex. The concentration of GABA was 1,730.3 AE 1,342.1 nmol/L (n = 12). Patients were also divided into two groups based on GABA concentrations. Specifically, we divided the patients into hyper-and hypoGABAergic groups using a GABA concentration cut-off of 500 nmol/L. No significant difference was observed in Glu concentrations between the two groups. However, the number of patients in the hyper-GABAergic group who had Glu measurements was higher than that in the hypo-GABAergic group.
There was a significant decrease in the concentration of Glu to 66.3% of the pre-cooling levels during the cooling period (p = 0.001). This reduction continued after the cooling (to 55.6%, p = 0.001, Fig. 3 ). The concentration of GABA decreased to 35.1% of the pre-cooling level during the cooling period (p = 0.13). This decrease continued after the cooling (to 35.5%, p = 0.12, solid column in Fig. 4) . The average reduction in the levels of GABA during the cooling was more remarkable than the decrease in the levels of Glu. However, this reduction was not significant because the GABA concentrations varied between the patients, especially when measured at the hippocampus. When only patients with GABA measurements at the cortex were included, the reduction in GABA levels during and after the cooling were significant (47.7%, p = 0.02; 48.2%, p = 0.04; meshed columns in Fig. 4) . We observed no differences in Glu or GABA concentrations in patients with hippocampal sclerosis (HS) or other pathologies. The patient with DNET had average Glu levels and the patient with astrocytoma had the lowest Glu levels. The reduction in Glu levels during the cooling was significant (p = 0.01). However, the reduction in GABA levels during the cooling was not significant (p = 0.15) in patients with HS.
The differences between Glu concentrations during the post-cooling period and the pre-cooling period correlated with the differences between ECoG power during the postcooling period and the pre-cooling period (r 2 = 0.68, steeper slope in Fig. 5 ). The correlation was weaker, but still positive (r 2 = 0.17, slower slope in Fig. 5 ), when one patient with an extreme increase in ECoG power and Glu was excluded. The differences in GABA concentration between the post-cooling and pre-cooling periods did not correlate with the differences in ECoG power between the post-cooling and pre-cooling periods (r 2 = 0.11, Fig. 6 ). The reduction in GABA concentration due to the cooling did not correlate with the reduction in Glu concentration due to the cooling (r 2 = 0.07). Microdialysis or FBC did not yield any adverse effects.
Discussion
We hypothesized that the balance between Glu and GABA would determine seizure frequency and generalization, such that patients with high Glu and low GABA would experience more frequent GTC. However, there was no correlation between seizure severity and the levels of these neurotransmitters. These results are consistent with those of Cavus et al., 20 who observed that disease duration, seizure frequency, and history of febrile seizures have no significant effects on interictal Glu levels. They suggested that Glu levels are not predictors or consequences of recurrent seizures. Another reason for the absence of a correlation between neurotransmitter concentration and clinical symptoms may be that the distribution of glutamatergic and GABAergic neurons is not uniform, even in the epileptogenic zone. The microdialysis probe inserted in the area measured neurotransmitter levels in a very small area, making it impossible to obtain a representative concentration for the entire focal area. Therefore, the concentrations of the neurotransmitters did not correlate with the patients' clinical symptoms. The levels of GABA did not correlate with anticonvulsant intake, although valproate increases GABA synthesis and decreases its metabolism, and zonisamide increases GABA release. 21 We observed no correlations with patient age, although GABA levels decrease 22 and GABA A receptors are desensitized during adolescence. 23 
Figure 4.
Extracellular c-aminobutyric acid (GABA) concentrations measured before, during, and after cooling. The concentration of GABA (solid columns) before cooling (red) and during cooling (blue). The reduction continues after the cooling stops (green). The concentration of cortical GABA (mesh columns) decreases significantly during (blue) and after (green) cooling compared to the period before cooling (red). **p < 0.05. Epilepsia ILAE Figure 5 . Correlations between focal brain cooling (FBC)-induced changes in glutamate (Glu) levels and electrocorticography (ECoG) power. The differences in Glu concentration between the post-cooling and pre-cooling periods correlate with the differences in ECoG power between the post-cooling and pre-cooling periods (r 2 = 0.68, steeper slope). The correlation was weaker, but was still positive (r 2 = 0.17, slower slope) when one patient with extreme increases in Glu and ECoG power was excluded. Epilepsia ILAE Figure 6 . The relationship between focal brain cooling (FBC)-induced changes in c-aminobutyric acid (GABA) concentration and electrocorticography (ECoG) power. The differences in GABA concentration between the post-cooling and pre-cooling periods do not correlate with difference in ECoG power between the post-cooling and pre-cooling periods (r 2 = 0.11). Epilepsia ILAE Radioisotope imaging of BDZ receptors did not show a correlation with neurotransmitter levels. Despite the suboptimal comparisons between patients, serial concentration changes in the same region are reliable.
We observed obvious reductions in ECoG power and Glu and GABA concentrations following FBC. However, only the decrease in Glu levels was statistically significant. When patients whose measurements were obtained at the hippocampus were excluded, the reduction in GABA levels during FBC was significant (p = 0.02). In addition to the fact that technical difficulties associated with obtaining measurements and performing the cooling procedure in the hippocampus may influence the data, GABA levels are highly variable in the hippocampus, as reported by Cavus et al. 6 These factors contributed to the nonsignificant differences in GABA levels. Another reason for the variable levels of GABA may be that hypothermia blocks rhythmic action potential discharges without abolishing action potentials of interneurons, leading to the production of GABA. 24, 25 We found a correlation between the rate of the coolinginduced decrease in ECoG power and the rate of the decrease in Glu levels, but not GABA levels. Brain cooling alters sodium channel gating properties and therefore inhibits neuronal depolarization during epileptogenesis. [24] [25] [26] This then leads to decreases in ECoG power. Neurotransmitter collection using microdialysis is thought to mainly involve neurotransmitters released from astrocyte rather than synapses, 27 although this is not yet completely established. 28 Extrasynaptic release of Glu and GABA is stimulated when astrocytes are activated. Therefore, decreases in Glu and GABA levels during the cooling period may not be the consequence of a decrease in discharge, but rather may be due to the inactivation of astrocytes. We hypothesize that FBC alters the threshold and frequency of neuronal discharge and inhibits neurotransmitter release from astrocytes. Reduced Glu levels then further decrease sensitization to neuronal discharge. On the other hand, reduced GABA levels have no influence on neuronal discharge. This may be why the decrease in ECoG power correlated with Glu, but not GABA, levels.
The small number of patients in the study, the heterogeneous cohort, which included patients with several different pathologies, and variations in the regions from which neurotransmitter levels were measured limit the significance of the results and the conclusion. Furthermore, the long-term effects of FBC on neurotransmitters were not assessed in this study. Short-term FBC can alleviate seizures, 14 but patients with intractable epilepsy may require repeated cooling. Continuous decreases in Glu levels may upregulate postsynaptic receptors and disturb reuptake by glutamate transporters, leading to a plateauing of the effects of FBC.
We are developing an implantable cooling device with a closed-loop cooling system for patients with intractable epilepsy with unresectable foci. A switch function predicting seizure onset is required in the system because the present results and previous work from our group indicates that there is a time lag in the ECoG response after the introduction of cooling. Recent advances in seizure prediction based on high-frequency oscillations or heart rate variability may help us to achieve this aim. There are also difficulties associated with the design of the electric power supply and with releasing the heat generated by the cooling device. We used an extracorporeal power source and a coolant circuit in the study. Both miniaturizing of the system and a shorter cooling duration are required for implantation of the device in humans. The results of this study and those of previous studies indicate that cooling for a few minutes is enough to stop seizures, as assessed by ECoG. However, 30 min of cooling is required to stabilize the irritability of the epileptic focus by reducing Glu, which may prevent recurrent seizures even if interictal spikes continue after the termination of cooling. To save electric power, cooling temperatures should be set as high as possible. As stated in the introduction, 33.5°C is not a low enough temperature to lead to a reduction in Glu levels. We have not determined whether modest cooling temperatures between 15 and 33.5°C reduce abnormal discharge and Glu levels. Although several aspects of the procedure are still uncharacterized, recent advances in precision devices have enabled the optimization of the FBC procedure through the collection of real-time information regarding ECoG and neurotransmitters.
Conclusion
Extracellular Glu and GABA concentrations and the effects of lowering brain temperature on these concentrations were measured in patients with epilepsy. FBC led to a significant decrease in Glu levels and a nonsignificant decrease in GABA levels. The decrease in Glu levels correlated with a decrease in ECoG power, whereas the decreases in GABA levels did not correlate with ECoG power.
